TipRanks
Sun Pharmaceutical Industries Limited (IN:SUNPHARMA)
:SUNPHARMA
India Market
SUNPHARMA
Sun Pharmaceutical Industries Limited
RESEARCH TOOLSreports
Want to see IN:SUNPHARMA full AI Analyst Report?

Sun Pharmaceutical Industries Limited (SUNPHARMA) Income Statement

24 Followers

Sun Pharmaceutical Industries Limited Income Statement

Last quarter (Q1 2027), Sun Pharmaceutical Industries Limited's total revenue was ₹153.00B, an increase of 10.46% from the same quarter last year. In Q1, Sun Pharmaceutical Industries Limited's net income was ₹28.95B. See Sun Pharmaceutical Industries Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
₹ 584.62B₹ 525.78B₹ 484.97B₹ 438.86B₹ 386.54B
Gross Profit
₹ 325.62B₹ 410.20B₹ 370.55B₹ 325.67B₹ 277.78B
Operating Expenses
₹ 190.08B₹ 132.05B₹ 126.30B₹ 106.63B₹ 94.87B
Depreciation and Amortization
₹ 29.38B₹ 25.75B₹ 25.57B₹ 25.30B₹ 21.44B
EBITDA
₹ 183.40B₹ 151.81B₹ 130.77B₹ 118.36B₹ 103.00B
Operating Income
₹ 135.53B₹ 278.15B₹ 244.24B₹ 219.04B₹ 182.91B
Other Income/Expenses
₹ 15.10B₹ -140.78B₹ -133.75B₹ -125.44B₹ -138.27B
Pretax Income
₹ 150.63B₹ 137.37B₹ 110.49B₹ 93.61B₹ 44.65B
Net Income
₹ 114.79B₹ 109.29B₹ 95.76B₹ 84.74B₹ 32.73B
Per Share Metrics
Basic EPS
₹ 47.80₹ 45.60₹ 39.91₹ 35.32₹ 13.64
Diluted EPS
₹ 47.80₹ 45.60₹ 39.91₹ 35.32₹ 13.64
Weighted Average Shares Outstanding
 2.40B 2.40B 2.40B 2.40B 2.40B
Weighted Average Shares Outstanding (Diluted)
 2.40B 2.40B 2.40B 2.40B 2.40B
Currency in INR

Sun Pharmaceutical Industries Limited Earnings and Revenue History